Dergiler / Türk Onkoloji Dergisi / 2021 / Cilt: 36 - Sayı: 3

The Clinical Impact of the Late Imaging with 18F-Fluorodeoxyglucose PET Texture Analysis in Invasive Lobular Breast Cancer

Sayfa
273–284
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Greater number of significantly correlations was found between histopathological variables and texture analysis of late imaging (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE Breast invasive lobular cancer (ILC) is one of the most difficult malignancies to diagnose and follow-up due to its tumor morphology.
📊
Temel Bulgular & Veri:In ILC, diagnostic sensitivity is lower with 18F-fluorodeoxyglucose ([18F] FDG) PET/CT compared to invasive ductal carcinoma (IDC).
💡
Sonuç & Katkı:Greater number of significantly correlations was found between histopathological variables and texture analysis of late imaging (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE Breast invasive lobular cancer (ILC) is one of the most difficult malignancies to diagnose and follow-up due to its tumor morphology. Tumor heterogeneity is the most important reason for treatment failure and diagnostic limitation. Identification of heterogeneity by a non-invasive method, texture analysis that can be done from positron emission tomography (PET), MR, and CT is developed. In ILC, diagnostic sensitivity is lower with 18F-fluorodeoxyglucose ([18F] FDG) PET/CT compared to invasive ductal carcinoma (IDC). In this study, the correlation between histopathological variables and the texture analysis of [18F] FDG PET/CT standard images, and also late images whose contribution to the diagnosis of many malignancies has been investigated are researched. METHODS Twenty ILC patients underwent standard and late [18F] FDG PET/CT imaging for staging between May 2007 and December 2018. T and N stages, histological and nuclear grades, estrogen receptor, progesterone receptor, human epidermal growth factor-2, and Ki-67 were recorded. RESULTS Thirty-two textural indices with conventional and formal indices and histogram values were calculated with LIFEx software to find heterogeneity in standard and late [18F] FDG PET/CT images. Conventional and discrete indices based on GLRM and GLZM are more correlated than other texture indices. Greater number of significantly correlations was found between histopathological variables and texture analysis of late imaging (p

🔖

Bu Makaleye Atıf Yap

FALAY, F. O., SEYMEN, H. (2022). The Clinical Impact of the Late Imaging with 18F-Fluorodeoxyglucose PET Texture Analysis in Invasive Lobular Breast Cancer. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 3, 273–284. https://ajindex.com/articles/639101

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. The Lancet. GLOBOCAN 2018: Counting the toll of cancer. Lancet 2018;392(10152):985
  2. Narayan AK, Lehman CD. Mammography screening guideline controversies: Opportunities to improve patient engagement in screening. J Am Coll Radiol 2020;17(5):633–6
  3. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005;93(9):1046–52
  4. Brawley O, Byers T, Chen A, Pignone M, Ransohoff D, Schenk M, et al. New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA 2011;306(22):2495–9
  5. Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, et al. Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes. Eur J Cancer 2008;44(1):73–83
  6. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289(11):1421–4
  7. Scheidhauer K, Walter C, Seemann MD. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. Eur J Nucl Med Mol Imaging 2004;31(Suppl 1):S70–9
  8. Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993;71(12):3920–5
  9. Buck AK, Schirrmeister H, Mattfeldt T, Reske SN. Biological characterisation of breast cancer by means of PET. Eur J Nucl Med Mol Imaging 2004;31(Suppl 1):S80–7
  10. Osborne JR, Port E, Gonen M, Doane A, Yeung H, Gerald W, et al. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: Microarray and immunohistochemical analysis. J Nucl Med 2010;51(4):543–50
  11. Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gönen M, Osborne JR, et al. Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma. J Nucl Med 2015;56(11):1674–80
  12. Dong A, Wang Y, Lu J, Zuo C. Spectrum of the breast lesions with increased 18F-FDG uptake on PET/CT. Clin Nucl Med 2016;41(7):543–57
  13. Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 2002;20(2):379–87
  14. Jung NY, Kim SH, Kim SH, Seo YY, Oh JK, Choi HS, et al. Effectiveness of breast MRI and (18)F-FDG PET/ CT for the preoperative staging